SWOG Cancer Research Network

SWOG Cancer Research Network SWOG is a global cancer research community that designs and conducts publicly funded clinical trials.

If you recently finished treatment for — or you will soon — you may be able to join S2417CD. The trial doesn’t invol...
08/25/2025

If you recently finished treatment for — or you will soon — you may be able to join S2417CD.
The trial doesn’t involve any medical treatment. Instead, it’s studying an educational website that was designed for colorectal cancer survivors and their family members or other support people. The site provides information about follow-up care and guidance for talking with a support person about care preferences. Researchers hope to learn if people are more likely to get recommended follow-up care if they’ve used the website.
Learn more at SWOG.org/S2417CD or call 1-800-4-CANCER and ask about study S2417CD.

New Trial Alert! The PROSPECT-Lung clinical trial is a new NCI study exploring innovative treatment options to help impr...
12/12/2024

New Trial Alert! The PROSPECT-Lung clinical trial is a new NCI study exploring innovative treatment options to help improve outcomes for patients diagnosed with lung cancer. By combining targeted therapies and immunotherapy, the trial seeks to enhance survival rates and quality of life. Find out more here: https://bit.ly/PROSPECTLung

Testing for certain features in cancer (called biomarkers) can tell doctors about what’s causing the cancer to grow. The...
10/23/2024

Testing for certain features in cancer (called biomarkers) can tell doctors about what’s causing the cancer to grow. The study is for adults just diagnosed with acute ( ) or syndrome ( ). It uses advanced biomarker testing to try to match patients with a myeloMATCH clinical trial for cancer treatment. Ask your doctor to learn more. You can also call 1-800-4-CANCER or visit swog.org/myeloMATCH.

is a large National Cancer Institute (NCI) research study testing treatments for adults with acute myeloid (AML) or ...
07/24/2024

is a large National Cancer Institute (NCI) research study testing treatments for adults with acute myeloid (AML) or syndrome (MDS).
Patients join before starting treatment and may have clinical trial options at all stages of treatment. myeloMATCH uses advanced testing to look for cancer biomarkers that can be targeted by new treatments.
To learn more, visit swog.org/myeloMATCH or call the NCI’s Cancer Information Service at 1-800-4-CANCER.

Address

24 Frank Lloyd Wright Drive
Ann Arbor, MI
48105

Website

Alerts

Be the first to know and let us send you an email when SWOG Cancer Research Network posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to SWOG Cancer Research Network:

Shortcuts

Share

Category